Abeona Therapeutics Inc vs Weibo Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Weibo Corp is far larger — about 4.6× Abeona Therapeutics Inc's market cap, and Weibo Corp pays a 7.75% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WB | |
|---|---|---|
Market Cap | $421.19M | $1.93B |
Sector | Health | Media |
52-Week High | $7.45 | $12.83 |
52-Week Low | $4.17 | $7.20 |
Enterprise Value | $276.10M | $1.20B |
Dividend Yield | — | 7.75% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →